Effects of withdrawal from repeated amphetamine exposure in peri-puberty on neuroplasticity-related genes in mice

Neuroscience

Volumn 250, Issue , 2013, Pages 222-231

  Calabrese, F ^a   Richetto, J ^a   Racagni, G ^a,b   Feldon, J ^c   Meyer, U ^c   Riva, M A ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c ETH ZURICH   (Switzerland)

Author keywords

Arc; BDNF; IEG; Neurodevelopment; Schizophrenia; Sensitization

Indexed keywords

AMPHETAMINE; BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE;

ADOLESCENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARC GENE; ARTICLE; BDNF GENE; BRAIN DISEASE; BRAIN MATURATION; CELL FUNCTION; CFOS GENE; CONTROLLED STUDY; DRUG EXPOSURE; DRUG REEXPOSURE; FRONTAL CORTEX; GENE; GENE CONTROL; GENE EXPRESSION; HIPPOCAMPUS; IMMEDIATE EARLY GENE; MALE; MOUSE; NERVE CELL PLASTICITY; NERVE POTENTIAL; NERVOUS SYSTEM DEVELOPMENT; NEUROMODULATION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUBERTY; SENSITIZATION; SIGNAL TRANSDUCTION; WITHDRAWAL SYNDROME;

4-(2-HYDROXYETHYL)-1-PIPERAZINEETHANESULFONIC ACID; AMPH; AMPHETAMINE; ARC; BDNF; BRAIN-DERIVED NEUROTROPHIC FACTOR; EGTA; ETHYLENE GLYCOL TETRAACETIC ACID; HEPES; IEG; IEGS; IMMEDIATE EARLY GENES; NEURODEVELOPMENT; POLYVINYLIDENE DIFLUORIDE; PVDF; REAL-TIME POLYMERASE CHAIN REACTION; RT-PCR; SAL; SALINE; SCHIZOPHRENIA; SDS; SENSITIZATION; SODIUM DODECYL SULFATE; UNTRANSLATED REGION; UTR;

AMPHETAMINE; ANIMALS; BLOTTING, WESTERN; BRAIN CHEMISTRY; BRAIN-DERIVED NEUROTROPHIC FACTOR; CENTRAL NERVOUS SYSTEM STIMULANTS; CYTOSKELETAL PROTEINS; GENE EXPRESSION; GENES, IMMEDIATE-EARLY; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; PREFRONTAL CORTEX; REAL-TIME POLYMERASE CHAIN REACTION; RNA; SIGNAL TRANSDUCTION; SUBSTANCE WITHDRAWAL SYNDROME; SYNAPTIC TRANSMISSION;

EID: 84881638445     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.07.018     Document Type: Article

References (44)

1. Aid T., Kazantseva A., Piirsoo M., Palm K., Timmusk T. Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res 2007, 85:525-535.
2. An J.J., Gharami K., Liao G.Y., Woo N.H., Lau A.G., Vanevski F., Torre E.R., Jones K.R., Feng Y., Lu B., Xu B. Distinct role of long 3' UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons. Cell 2008, 134:175-187.
3. Andersen S.L. Trajectories of brain development: point of vulnerability or window of opportunity?. Neurosci Biobehav Rev 2003, 27:3-18.
4. Andersen S.L. Stimulants and the developing brain. Trends Pharmacol Sci 2005, 26:237-243.
5. Angelucci F., Gruber S.H., El Khoury A., Tonali P.A., Mathe A.A. Chronic amphetamine treatment reduces NGF and BDNF in the rat brain. Eur Neuropsychopharmacol 2007, 17:756-762.
6. Autry A.E., Monteggia L.M. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 2012, 64:238-258.
7. Boileau I., Dagher A., Leyton M., Gunn R.N., Baker G.B., Diksic M., Benkelfat C. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men. Arch Gen Psychiatry 2006, 63:1386-1395.
8. Bramham C.R., Messaoudi E. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol 2005, 76:99-125.
9. Brook D.W., Brook J.S., Zhang C., Cohen P., Whiteman M. Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Arch Gen Psychiatry 2002, 59:1039-1044.
10. Buka S.L., Fan A.P. Association of prenatal and perinatal complications with subsequent bipolar disorder and schizophrenia. Schizophr Res 1999, 39:113-119. discussion 160-111.
11. Calabrese F., Molteni R., Racagni G., Riva M.A. Neuronal plasticity: a link between stress and mood disorders. Psychoneuroendocrinology 2009, 34(Suppl. 1):S208-S216.
12. Cheng C.Y., Hong C.J., Yu Y.W., Chen T.J., Wu H.C., Tsai S.J. Brain-derived neurotrophic factor. Val66Met) genetic polymorphism is associated with substance abuse in males. Brain Res Mol Brain Res 2005, 140:86-90.
13. Curran C., Byrappa N., McBride A. Stimulant psychosis: systematic review. Br J Psychiatry 2004, 185:196-204.
14. Fanous S., Lacagnina M.J., Nikulina E.M., Hammer R.P. Sensitized activation of Fos and brain-derived neurotrophic factor in the medial prefrontal cortex and ventral tegmental area accompanies behavioral sensitization to amphetamine. Neuropharmacology 2011, 61:558-564.
15. Flanagin B.A., Cook E.H., de Wit H. An association study of the brain-derived neurotrophic factor Val66Met polymorphism and amphetamine response. Am J Med Genet B Neuropsychiatr Genet 2006, 141B:576-583.
16. Fletcher P.J., Tenn C.C., Sinyard J., Rizos Z., Kapur S. A sensitizing regimen of amphetamine impairs visual attention in the 5-choice serial reaction time test: reversal by a D1 receptor agonist injected into the medial prefrontal cortex. Neuropsychopharmacology 2007, 32:1122-1132.
17. Hedou G., Jongen-Relo A.L., Murphy C.A., Heidbreder C.A., Feldon J. Sensitized Fos expression in subterritories of the rat medial prefrontal cortex and nucleus accumbens following amphetamine sensitization as revealed by stereology. Brain Res 2002, 950:165-179.
18. Hutchinson A.N., Deng J.V., Aryal D.K., Wetsel W.C., West A.E. Differential regulation of MeCP2 phosphorylation in the CNS by dopamine and serotonin. Neuropsychopharmacology 2012, 37:321-337.
19. Hyman C., Hofer M., Barde Y.A., Juhasz M., Yancopoulos G.D., Squinto S.P., Lindsay R.M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 1991, 350:230-232.
20. Ito R., Canseliet M. Amphetamine exposure selectively enhances hippocampus-dependent spatial learning and attenuates amygdala-dependent cue learning. Neuropsychopharmacology 2010, 35:1440-1452.
21. Kim D.J., Roh S., Kim Y., Yoon S.J., Lee H.K., Han C.S., Kim Y.K. High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users. Neurosci Lett 2005, 388:112-115.
22. Laruelle M. The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Res Brain Res Rev 2000, 31:371-384.
23. Lessmann V., Gottmann K., Malcangio M. Neurotrophin secretion: current facts and future prospects. Prog Neurobiol 2003, 69:341-374.
24. Lewis D.A., Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 2002, 25:409-432.
25. McCambridge J., McAlaney J., Rowe R. Adult consequences of late adolescent alcohol consumption: a systematic review of cohort studies. PLoS Med 2011, 8:e1000413.
26. McGee R., Williams S., Poulton R., Moffitt T. A longitudinal study of cannabis use and mental health from adolescence to early adulthood. Addiction 2000, 95:491-503.
27. Meredith G.E., Callen S., Scheuer D.A. Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration. Brain Res 2002, 949:218-227.
28. Moll G.H., Mehnert C., Wicker M., Bock N., Rothenberger A., Ruther E., Huether G. Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood. Brain Res Dev Brain Res 2000, 119:251-257.
29. Murphy C.A., Fend M., Russig H., Feldon J. Latent inhibition, but not prepulse inhibition, is reduced during withdrawal from an escalating dosage schedule of amphetamine. Behav Neurosci 2001, 115:1247-1256.
30. Paulson P.E., Robinson T.E. Sensitization to systemic amphetamine produces an enhanced locomotor response to a subsequent intra-accumbens amphetamine challenge in rats. Psychopharmacology (Berl) 1991, 104:140-141.
31. Paxinos, G., Watson, C., 1996. The Rat Brain in Stereotaxis Coordinates. Academic Press, New York.
32. Peleg-Raibstein D., Feldon J. Effects of withdrawal from an escalating dose of amphetamine on conditioned fear and dopamine response in the medial prefrontal cortex. Behav Brain Res 2008, 186:12-22.
33. Peleg-Raibstein D., Sydekum E., Feldon J. Differential effects on prepulse inhibition of withdrawal from two different repeated administration schedules of amphetamine. Int J Neuropsychopharmacol 2006, 9:737-749.
34. Peleg-Raibstein D., Yee B.K., Feldon J., Hauser J. The amphetamine sensitization model of schizophrenia: relevance beyond psychotic symptoms?. Psychopharmacology (Berl) 2009, 206:603-621.
35. Poo M.M. Neurotrophins as synaptic modulators. Nat Rev Neurosci 2001, 2:24-32.
36. Richetto J., Feldon J., Riva M.A., Meyer U. Comparison of the long-term consequences of withdrawal from repeated amphetamine exposure in adolescence and adulthood on information processing and locomotor sensitization in mice. Eur Neuropsychopharmacol 2013, 23:160-170.
37. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 1986, 396:157-198.
38. Russig H., Murphy C.A., Feldon J. Prepulse inhibition during withdrawal from an escalating dosage schedule of amphetamine. Psychopharmacology (Berl) 2003, 169:340-353.
39. Schepis T.S., Adinoff B., Rao U. Neurobiological processes in adolescent addictive disorders. Am J Addict 2008, 17:6-23.
40. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 2000, 24:417-463.
41. Tenn C.C., Fletcher P.J., Kapur S. Amphetamine-sensitized animals show a sensorimotor gating and neurochemical abnormality similar to that of schizophrenia. Schizophr Res 2003, 64:103-114.
42. Tenn C.C., Kapur S., Fletcher P.J. Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition. Psychopharmacology (Berl) 2005, 180:366-376.
43. Timmusk T., Palm K., Metsis M., Reintam T., Paalme V., Saarma M., Persson H. Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 1993, 10:475-489.
44. Weiner I., Lubow R.E., Feldon J. Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacol Biochem Behav 1988, 30:871-878.